Relevium Technologies CEO Describes Solid Growth Opportunities in Health & Wellness Sectors

Relevium Technologies’ (TSXV: RLV – $0.27 & Fra: 6BX – €0.13) corporate strategy is to acquire companies with e-retail brands, products and technologies in the health and wellness industries focusing on the nutraceutical and cosmeceutical market niches. As the Company’s sales are growing rapidly on popular e-commerce platforms, we felt it was high time to sit down with Mr. Aurelio Useche, Relevium’s Chief Executive Officer.

Mr. Useche delivers plenty of valuable information about Relevium’s growing number of products that it has on the market. In addition, he shares that the number will continue to increase the coming weeks and months.

In fact, just this week, the Company signed an exclusive deal with HempCo Canada for the Planet Hemp brand. Under the agreement, Relevium will market Planet Hemp products in both the US and UK and exclusively online through Amazon, Walmart/Jet and others. The two companies will further cooperate in the business development, branding, marketing and e-retailing of Planet Hemp and all the Hempco products.

Next to HempCo, Relevium also has partnerships with other firms to expand its product lines. For example, the Company will launch an exclusive brand of nutraceuticals and phytoceuticals for pets and livestock next year.

The interview also takes a look at the Company’s growth opportunities through acquisitions. Last June, Relevium completed the acquisition of nutraceutical product company BioGanix for US$5.8 million (3.7X EBIT). The buyout brought BioGanix’s website properties, formulations, inventory and product pipeline under the Relevium umbrella.

BioGanix has a strong e-commerce presence, generating 90% of its trailing-twelve-month C$5 million in revenue and C$1.3 in trailing-twelve-month cash flow from Amazon. In the quarter ended September 30, 2017 sales for BioGanix increased by 47%, as compared to sales during the same period last year under the previous ownership. Relevium targets to acquire a company every six months.

Moreover, Mr. Useche introduces the Company’s well-experienced management team, and reveals his plans to grow the Company to sales of $70 million by 2019.

Access our interview by clicking the play button on the media player below.

Smallcaps.us Advice: Buy	Price Target: $1.08	Latest Company Report (pdf)
For important disclosures, please read our disclaimer.